Product category:
Pharmaceutical Processing News
News Release from: Intertek Caleb Brett
Edited by the Processingtalk Editorial
Team on 15 February 2008
Intertek acquires BioClin laboratory in
Ireland
Intertek, the leading international provider of quality and safety services, has acquired BioClin Research Laboratories, with their bio-analytical and pharmaceutical product analysis capabilities
BioClin is one of Ireland's leading suppliers of contract bio-analysis and analytical research and development, with advanced analytical services including liquid chromatography-tandem mass spectrometry (LC/MS/MS) BioClin has been serving the local and international pharmaceutical, medical device and drug delivery industry for more than five years
This article was originally published on Processingtalk on 9 Jul 2003 at 8.00am (UK)
Related stories
Robot army for Land Rover
ABB, the global power and automation technologies group, announced today that it has won an order from Ford Premier Automotive Group to supply 186 industrial robots to Land Rover
ABB creates new Nationwide instrumentation network
A new comprehensive instrumentation supply and service network has been created by ABB to serve customers throughout the UK: the Instrumentation Alliance comprises five carefully selected partners
Located in Athlone and with 20 staff, BioClin is highly regarded for its technical expertise, rigorous compliance programmes, and outstanding customer service.
The laboratory is Good Laboratory Practice (GLP) certified and is a current Good Manufacturing Practice (cGMP) facility that has been inspected by the IMB.
The acquisition advances the Intertek strategic growth in expert support services to the global pharmaceutical, medical device and drug delivery industry.
BioClin will operate in the Intertek Pharmaceutical Services group within its Analytical Services division.
Dr Andrew Swift, Executive Vice President of Intertek Analytical Services Division, comments: "BioClin has a strong reputation in the industry.
Acquiring BioClin, further expands the Intertek support globally to the pharmaceutical and related sectors for outsourced R+D and analytical services".
Dr John Conti-Ramsden, Global Director of Intertek Pharmaceutical Services, said: "BioClin further extends our offering in Europe as well as our global platform supporting pharmaceutical R+D and manufacturing in key locations.
Intertek already provides a wide range of testing services to pharmaceutical clients from its laboratories in the United Kingdom, USA, India and Australia".
Mary Burke, Managing Director and Brian McKenna PhD, Scientific Director of BioClin commented jointly: "Joining Intertek will allow the BioClin local and international clients to gain from the Intertek global network and surrounding experts and facilities.
It also gives BioClin an exciting opportunity to provide our expert services to a wider network of new international clients and markets".
• Intertek Caleb Brett: contact details and other news
• Email this article to a colleague
• Register for the free Processingtalk email newsletter
• Processingtalk Home Page
Search the Pro-Talk network of sites
